The Effect of Power-walking in Phase 2 Cardiac Rehabilitation Program
- PMID: 22506246
- PMCID: PMC3309327
- DOI: 10.5535/arm.2012.36.1.133
The Effect of Power-walking in Phase 2 Cardiac Rehabilitation Program
Abstract
Objective: To evaluate the effects of power walking (PW) training on a treadmill in patients with coronary heart disease (CHD) and to compare the cardiovascular effects of PW with usual walking (UW).
Method: Patients were recruited as participants in phase 2 cardiac rehabilitation program after receiving percutaneous coronary intervention (PCI) due to acute coronary syndrome from our hospital. The participants were divided into the PW group (n=16) and UW group (n=18). All participants received graded exercise test (GXT) and significant difference in maximal oxygen consumption (VO(2Max)) was not observed between the groups. Aerobic exercise training on treadmill was given for 50 minutes per session, three times a week, for six weeks. Physiological and hematological parameters were tested before and 6 weeks after the cardiac rehabilitation program. Exercise duration, VO(2Max), heart rate, blood pressure, and rate pressure product were evaluated through graded exercise test. Hematological measurements included serum lipid profile, and high-sensitivity C reactive protein (hs-CRP).
Results: There were no significant differences in resting heart rate, maximal heart rate, resting systolic and diastolic blood pressures, lipid profile, hs-CRP, VO(2Max), and RPP between the PW group and UW group. However, after 6 weeks of the intervention, VO(2Max) in the PW group (36.03±5.69 ml/kg/min) was significantly higher than that in the UW group (29.73±5.63 ml/kg/min) (p<0.05).
Conclusion: After six weeks of phase 2 cardiac rehabilitation program, the PW group showed significant improvement in VO(2Max) than the UW group. Thus, it will beneficial to recommend power walking in cardiac rehabilitation program.
Keywords: Cardiovascular disease; Exercise; Rehabilitation; Walking.
Figures
References
-
- Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation. 2003;107:3109–3116. - PubMed
-
- Kelley GA, Kelley KS, Tran ZV. Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med. 2004;38:651–661. - PubMed
-
- Kelley GA, Kelley KS, Tran ZV. Walking and resting blood pressure in adults: a meta-analysis. Prev Med. 2001;33:120–127. - PubMed
-
- Franklin BA. Walking: the undervalued prescription. Prev Cardiol. 2006;9:56–59. - PubMed
-
- Quell KJ, Porcari JP, Franklin BA, Foster C, Andreuzzi RA, Anthony RM. Is brisk walking an adequate aerobic training stimulus for cardiac patients? Chest. 2002;122:1852–1856. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous